Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A new report from a research group called Big Chalk Analytics shows that oral weight-loss pills are about to bring in a massive wave of new patients. Many people who dislike needles are looking forward to a simple, daily pill…
Europe’s top drug regulator has moved closer to approving a daily weight-loss pill. The Committee for Medicinal Products for Human Use (CHMP), operating under the European Medicines Agency (EMA), issued a positive opinion for once-daily oral semaglutide 25 mg, sold…
The landscape of metabolic health is undergoing a massive transformation in the year 2026. Global medical breakthroughs have finally provided patients with diverse ways to manage their long-term weight goals. In view of this, the choice between a daily glucagon-like…
The oral glucagon-like peptide-1 (GLP-1) weight-loss market is entering a period of rapid expansion. In view of this, GlobalData forecasts weight-loss pill revenues will rise to $34.3 billion. To be precise, this growth will disrupt traditional retail food and beverage…